Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Large-scale testing (Phase 3)Looking for participantsNCT05531565
What this trial is testing

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Who this might be right for
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
Biogen 450
Testing effectiveness (Phase 2)Study completedNCT05162586
What this trial is testing

The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)

Who this might be right for
Systemic Lupus Erythematosus
EMD Serono Research & Development Institute, Inc. 456
Testing effectiveness (Phase 2)Looking for participantsNCT07260877
What this trial is testing

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)Systemic Lupus ErythematosusSLE+2 more
Ventus Therapeutics U.S., Inc. 24
Testing effectiveness (Phase 2)UnknownNCT03260166
What this trial is testing

Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus

Who this might be right for
Cutaneous Lupus ErythematosusSystemic Lupus Erythematosus Rash
Second Xiangya Hospital of Central South University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06625671
What this trial is testing

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

Who this might be right for
Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus
DualityBio Inc. 148
Large-scale testing (Phase 3)Looking for participantsNCT07355218
What this trial is testing

Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

Who this might be right for
Systematic Lupus ErythematosusCutaneous Lupus Erythematosus
EMD Serono Research & Development Institute, Inc. 202
Early research (Phase 1)Active Not RecruitingNCT05411016
What this trial is testing

KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus

Who this might be right for
Healthy VolunteersSystemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
Kyowa Kirin Co., Ltd. 157
Testing effectiveness (Phase 2)Active Not RecruitingNCT05540327
What this trial is testing

The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)

Who this might be right for
Systemic Lupus Erythematosus
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 379
Early research (Phase 1)Not Yet RecruitingNCT07306585
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HC022 Injection in Subjects With SLE/CLE

Who this might be right for
Systemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
HC Biopharma Inc. 32
Large-scale testing (Phase 3)Looking for participantsNCT07332481
What this trial is testing

Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

Who this might be right for
Systemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
EMD Serono Research & Development Institute, Inc. 202
Testing effectiveness (Phase 2)Study completedNCT02847598
What this trial is testing

Study to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus ErythematosusActive Cutaneous Lupus Erythematosus
Biogen 264
Post-approval studies (Phase 4)Looking for participantsNCT06875960
What this trial is testing

Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

Who this might be right for
Systemic Lupus Erythematosus (SLE)Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
Bristol-Myers Squibb 35
Not applicableStudy completedNCT00513591
What this trial is testing

Duke Autoimmunity in Pregnancy Registry

Who this might be right for
PregnancySystemic Lupus ErythematosusCutaneous Lupus+3 more
Duke University 513
Large-scale testing (Phase 3)Study completedNCT01551069
What this trial is testing

Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion

Who this might be right for
Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Sanofi 103
Early research (Phase 1)Study completedNCT06013995
What this trial is testing

Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus

Who this might be right for
Lupus
Bristol-Myers Squibb 45
Testing effectiveness (Phase 2)Ended earlyNCT05879718
What this trial is testing

Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.

Who this might be right for
Lupus Erythematosus, SystemicLupus Erythematosus, Cutaneous
Pfizer 8